Payment overview · 2025
General Payments
$75.82
3 reported records · 2 companies
Healthcare provider profile · identity verified
Owen Capocyan, M.D.
Allopathic & Osteopathic Physicians|Family Medicine|Geriatric Medicine · SUGAR LAND, TX · NPI 1063695328
Verified facts
What the public records show
CMS Open Payments records show Owen Capocyan, M.D. received $75.82 in general payments during 2025 across 3 reported records.
SK Life Science, Inc. accounted for 78.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| SK Life Science, Inc. |
SK Life Science, Inc. exact · evidence 2025-04-03 |
$59.20 | 78.1% | 2 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $16.62 | 21.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $75.82 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Cologuard Collection Kit Normalized: cologuard collection kit |
Device | Exact Sciences Corporation | $16.62 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 612 | 131 |
| Levothyroxine Sodium | Levothyroxine Sodium | 548 | 91 |
| Eliquis | Apixaban | 492 | 55 |
| Furosemide | Furosemide | 432 | 85 |
| Potassium Chloride | Potassium Chloride | 430 | 75 |
| Lisinopril | Lisinopril | 400 | 69 |
| Amlodipine Besylate | Amlodipine Besylate | 362 | 74 |
| Memantine Hcl | Memantine Hcl | 343 | 61 |
| Donepezil Hcl | Donepezil Hcl | 342 | 67 |
| Divalproex Sodium | Divalproex Sodium | 333 | 55 |
| Metformin Hcl | Metformin Hcl | 307 | 63 |
| Losartan Potassium | Losartan Potassium | 306 | 64 |
| Metoprolol Tartrate | Metoprolol Tartrate | 298 | 59 |
| Gabapentin | Gabapentin | 294 | 60 |
| Trazodone Hcl | Trazodone Hcl | 282 | 47 |
| Enulose | Lactulose | 267 | 43 |
| Carvedilol | Carvedilol | 240 | 42 |
| Quetiapine Fumarate | Quetiapine Fumarate | 237 | 31 |
| Sertraline Hcl | Sertraline Hcl | 236 | 50 |
| Tamsulosin Hcl | Tamsulosin Hcl | 227 | 47 |
| Mirtazapine | Mirtazapine | 219 | 45 |
| Clopidogrel | Clopidogrel Bisulfate | 207 | 35 |
| Buspirone Hcl | Buspirone Hcl | 199 | 31 |
| Escitalopram Oxalate | Escitalopram Oxalate | 190 | 34 |
| Levetiracetam | Levetiracetam | 188 | 26 |
| Jardiance | Empagliflozin | 156 | 13 |
| Januvia | Sitagliptin Phosphate | 132 | 14 |
| Hydrochlorothiazide | Hydrochlorothiazide | 125 | 35 |
| Duloxetine Hcl | Duloxetine Hcl | 116 | 15 |
| Amiodarone Hcl | Amiodarone Hcl | 114 | 27 |
| Aptiom | Eslicarbazepine Acetate | 106 | suppressed |
| Metoprolol Succinate | Metoprolol Succinate | 105 | 31 |
| Omeprazole | Omeprazole | 105 | 31 |
| Gemtesa | Vibegron | 102 | 11 |
| Pantoprazole Sodium | Pantoprazole Sodium | 93 | 30 |
| Hydralazine Hcl | Hydralazine Hcl | 90 | 19 |
| Finasteride | Finasteride | 89 | 17 |
| Prednisone | Prednisone | 84 | 51 |
| Xarelto | Rivaroxaban | 83 | suppressed |
| Risperidone | Risperidone | 76 | 17 |
| Latanoprost | Latanoprost | 74 | 15 |
| Farxiga | Dapagliflozin Propanediol | 71 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 65 | 11 |
| Digoxin | Digoxin | 63 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 60 | 26 |
| Midodrine Hcl | Midodrine Hcl | 60 | 13 |
| Diclofenac Sodium | Diclofenac Sodium | 58 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 57 | suppressed |
| Ozempic | Semaglutide | 56 | 12 |
| Simvastatin | Simvastatin | 56 | 13 |
| Allopurinol | Allopurinol | 54 | 17 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 54 | 32 |
| Levofloxacin | Levofloxacin | 53 | 37 |
| Olanzapine | Olanzapine | 53 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 53 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 52 | 11 |
| Alendronate Sodium | Alendronate Sodium | 50 | 15 |
| Chlorpromazine Hcl | Chlorpromazine Hcl | 49 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 49 | 39 |
| Oxcarbazepine | Oxcarbazepine | 49 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 49 | 12 |
| Meloxicam | Meloxicam | 48 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 46 | 19 |
| Paroxetine Hcl | Paroxetine Hcl | 46 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 45 | 17 |
| Brilinta | Ticagrelor | 45 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 44 | 31 |
| Lidocaine Hcl | Lidocaine Hcl | 44 | 27 |
| Aripiprazole | Aripiprazole | 42 | suppressed |
| Famotidine | Famotidine | 42 | 15 |
| Tresiba Flextouch U-100 | Insulin Degludec | 42 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 41 | suppressed |
| Baclofen | Baclofen | 40 | suppressed |
| Glipizide | Glipizide | 40 | suppressed |
| Cyclosporine | Cyclosporine | 39 | suppressed |
| Irbesartan | Irbesartan | 39 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 39 | 14 |
| Sulfasalazine | Sulfasalazine | 39 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 37 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 36 | 11 |
| Sevelamer Carbonate | Sevelamer Carbonate | 36 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 34 | 21 |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 34 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 33 | 30 |
| Fluconazole | Fluconazole | 33 | 13 |
| Nebivolol Hcl | Nebivolol Hcl | 33 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 33 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 32 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 32 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 32 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 32 | suppressed |
| Amantadine | Amantadine Hcl | 30 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 30 | 30 |
| Bupropion Xl | Bupropion Hcl | 30 | suppressed |
| Nyamyc | Nystatin | 30 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 30 | 11 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 29 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 29 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 20 |
| Primidone | Primidone | 28 | suppressed |
| Lovastatin | Lovastatin | 27 | suppressed |
| Spironolactone | Spironolactone | 27 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 26 | suppressed |
| Nifedipine Er | Nifedipine | 26 | suppressed |
| Xifaxan | Rifaximin | 26 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 26 | suppressed |
| Flavoxate Hcl | Flavoxate Hcl | 25 | suppressed |
| Nystatin | Nystatin | 25 | 16 |
| Propranolol Hcl | Propranolol Hcl | 25 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 25 | suppressed |
| Bumetanide | Bumetanide | 24 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 24 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 24 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 24 | suppressed |
| Azithromycin | Azithromycin | 23 | 14 |
| Lactulose | Lactulose | 23 | 14 |
| Cilostazol | Cilostazol | 22 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 22 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 22 | 17 |
| Atenolol | Atenolol | 21 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Nuplazid | Pimavanserin Tartrate | 21 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 20 | suppressed |
| Ketoconazole | Ketoconazole | 20 | suppressed |
| Torsemide | Torsemide | 20 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 19 | suppressed |
| Linzess | Linaclotide | 19 | suppressed |
| Pregabalin | Pregabalin | 19 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 18 | suppressed |
| Trulicity | Dulaglutide | 18 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 17 | suppressed |
| Cefdinir | Cefdinir | 17 | 11 |
| Lamotrigine | Lamotrigine | 16 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 16 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 15 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 15 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Gemfibrozil | Gemfibrozil | 15 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 15 | suppressed |
| Paliperidone Er | Paliperidone | 15 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 15 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 14 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 14 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 14 | suppressed |
| Haloperidol | Haloperidol | 14 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 14 | suppressed |
| Lorazepam | Lorazepam | 14 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 14 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 14 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 14 | suppressed |
| Alprazolam | Alprazolam | 13 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 13 | suppressed |
| Febuxostat | Febuxostat | 13 | suppressed |
| Galantamine Er | Galantamine Hbr | 13 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 13 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 13 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 13 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 13 | suppressed |
| Metolazone | Metolazone | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Rayaldee | Calcifediol | 13 | suppressed |
| Ursodiol | Ursodiol | 13 | suppressed |
| Acetazolamide | Acetazolamide | 12 | suppressed |
| Diltiazem 12hr Er | Diltiazem Hcl | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 12 | suppressed |
| Acarbose | Acarbose | 11 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Aranesp | Darbepoetin Alfa In Polysorbat | 11 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 11 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Levemir Flexpen | Insulin Detemir | 11 | suppressed |
| Myrbetriq | Mirabegron | 11 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $75.82 · 3 records | SK Life Science, Inc. | Cologuard Collection Kit | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error